NIH-funded research R01 grant

Risk prediction for aortic stenosis and how statins might help in adults 75 and older

Official title: Risk Prediction for aortic stenosis and the impact of statin therapy among adults >75 years old in the PREVENTABLE trial

Funded at Johns Hopkins University · NIH-11429920 · Data updated 2026-11-12

This grant seeks to identify which adults over 75 are at high risk for aortic valve disease and how statin therapy could influence that risk.

More Aortic Stenosis research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionJohns Hopkins University
NIH-funded
Lab location1 site (Baltimore, United States)
Project startSeptember 1, 2026
Project endMay 31, 2031
Funding year2026
Award (this year)$632,235
NIH project number1R01HL188732-01
Project IDNIH-11429920 on NIH RePORTER

Who could benefit from this research

Could help

Adults aged 75 and older who have or are at risk for calcific aortic valve disease and are being considered for lipid-lowering therapy.

Less likely to help

The findings may be less directly helpful for younger individuals or those without risk factors for aortic valve disease.

What this research studies

If you are 75 or older and have concerns about your heart valves, this project aims to create a better way to spot those at high risk for aortic stenosis due to calcification. The research will examine how cholesterol-lowering meds like statins could impact the progression of valve disease and related risks such as dementia or stroke. By using data from real-world adults and focusing on age-specific factors, the study hopes to develop practical risk-prediction methods that could guide future prevention choices. The team at Johns Hopkins plans to analyze patterns in lipids, inflammation, and valve calcium to identify potential intervention points.

Why it matters

Potential benefit: A clearer picture of who is at high risk could lead to earlier, personalized prevention strategies and better management of valve health in older adults.

How similar studies have gone: Previous analyses hint that lipid-lowering therapy might influence valve disease risk, but robust, age-specific evidence is lacking.

Where this research is happening

  • Johns Hopkins University
    Baltimore, United States
    Active

Researchers

  • Principal investigator: Whelton, Seamus Paul — Johns Hopkins University
  • Study coordinator: Whelton, Seamus Paul

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.